Danone set to double its sales in India over the next three years
Danoneâs products are sold on five continents, and the company has over 180 production plants and about 100,000 employees.
In 2011, Danone generated sales of âŹ19bn, of which more than half were in emerging markets. Indiaâs baby nutrition market is valued at about 25bn rupees (âŹ0.35bn), in which Danone holds about an 8% share.
âIndiaâs growth in the nutrition sector will outpace Chinaâs growth. We are here to expand. Baby nutrition is typically the kind of category where the market grows at 15%-20% annually,â said Laurent Marcel, managing director at Danoneâs India nutrition business unit.
âWe should grow faster than the market. We should be able to double our business in three to four years. That is the ambition. It is a growing business.â
Earlier this year, the group acquired Indian drugmaker Wockhardtâs for about âŹ275m. Wockhardtâs is a nutrition business that sells popular brands such as Dexolac, Farex, and Nusobee. The brands compete with Danoneâs principal global rival Nestle.
Mr Marcel said the groupâs holding company Nutricia expects to leverage the existing Danone and Wockhardtâs brands in India.
The sales expansion will begin once the company has developed its understanding of the local market. Mr Marcel said: âWe will get our international products [into the Indian market], but at this time it is too early which products we will get.â
Danoneâs new âŹ50m plant in Macroom, Co Cork, is due to be operational in early Jan 2013. That investment will double the Cork plantâs production capacity to 70,000 tonnes of infant nutrition products annually, including brands such as Aptamil and Cow & Gate.
Earlier this year, Danone told the markets its intention to build sales in emerging economies was partly driven by a âswift deterioration in consumptionâ in southern Europe.
Danone also recently announced the successful launch of a âŹ750m five-year bond issue. Danone said the funds raised will enable the company to diversify its sources of finance and extend the maturity of its debt at favourable market conditions.





